News
-
-
-
-
-
-
-
REGULATED PRESS RELEASE
Reporting on share buyback transactions carried out between March 17 and March 21, 2025
Compagnie de Saint-Gobain reports share buyback transactions in compliance with EU market abuse regulation, total buyback volume of 94,045 shares worth 9,401,820 euros from March 17 to 21, 2025 -
-
PRESS RELEASE
Newron proposes renowned biopharma company founder and entrepreneur Dr. Chris Martin for election as Independent Chairman
Newron Pharmaceuticals S.p.A. proposes Chris Martin, ex-CEO of ADC Therapeutics, as Independent Chairman succeeding Dr. Köstlin after 12 years. Martin an experienced biopharma leader -